Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer
Study population We studied three independent cohorts of patients with NSCLC who were treated with PD-1-based immunotherapies in the advanced or metastatic setting. The clinical characteristics of the cohorts are…
Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies
When a person develops solid tumors in the stomach or esophagus or rectum, oncologists know how to treat them. But the cures often come with severe effects on quality of…